Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | COYACoya Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $7.95M |
| Revenue, yoy | +123.6% |
| Net income | $21.23M |
| Net income, yoy | −42.6% |
| Net margin | -267.1% |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $1.27 |
Add another company.